Antimicrobial Agents Practice Questions

Q: Anterior nares is the most common site of colonization in the carrier state of MRSA. What is the best treatment?

Topical mupirocin. The anterior nares serve as the primary reservoir for *Staphylococcus aureus*, including Methicillin-resistant *S. aureus* (MRSA) [1]. To eradicate the carrier state and prevent the spread of infection (especially in healthcare workers or pre-operative patients), a localized, high-concentration treatment is required. **Mupirocin (Pseudomonic acid A)** is the drug of choice for this purpose [2]. It works by inhibiting **isoleucyl-tRNA synthetase**, thereby halting bacterial protein synthesis. Its topical application ensures high local concentrations that effectively clear the colonization without systemic side effects. **2. Why the Other Options are Incorrect:** * **Oral Vancomycin:** Vancomycin is not absorbed from the GI tract [1]. It is used orally only for *Clostridioides difficile* colitis. For systemic MRSA, it must be given IV [1]. It is not used for nasal decolonization. * **Inhaled Colistin:** This is used for treating multi-drug resistant Gram-negative infections (like *Pseudomonas*) in cystic fibrosis or ventilator-associated pneumonia, not for Gram-positive nasal colonization [2]. * **IV Cefazolin:** Cefazolin is a first-generation cephalosporin. By definition, **MRSA is resistant to all beta-lactams** (except 5th generation cephalosporins like Ceftaroline) due to the altered penicillin-binding protein (PBP2a).

Q: Sulfonamides inhibit bacterial synthesis of folic acid by:

Competitive inhibition.. **Explanation:** **1. Why Competitive Inhibition is Correct:** Sulfonamides are structural analogs of **Para-Aminobenzoic Acid (PABA)** [1], [2], [3]. In the bacterial folic acid synthesis pathway, the enzyme **Dihydropteroate Synthase** normally utilizes PABA to produce dihydrofolic acid [2]. Because sulfonamides closely resemble PABA, they compete for the same active site on the enzyme [1], [2]. This is a classic example of **competitive inhibition**, which can be reversed by increasing the concentration of the substrate (PABA). Since bacteria must synthesize their own folic acid (unlike humans who absorb it from diet), this inhibition leads to "thymineless death" of the bacteria [1], [3]. **2. Why Other Options are Incorrect:** * **Uncompetitive Inhibition:** The inhibitor binds only to the enzyme-substrate (ES) complex, not the free enzyme. Sulfonamides bind to the free enzyme. * **Allosteric/Non-competitive Inhibition:** These involve binding to a site other than the active site (allosteric site), causing a conformational change. Sulfonamides specifically target the active site where PABA binds [1], [2]. **3. NEET-PG Clinical Pearls & High-Yield Facts:** * **Synergy:** Sulfonamides are often combined with **Trimethoprim** (e.g., Co-trimoxazole) to achieve **sequential blockade** [1], [2], [3]. Trimethoprim inhibits the next step in the pathway: *Dihydrofolate Reductase (DHFR)* [1], [3]. * **Selectivity:** Humans are unaffected because we lack dihydropteroate synthase and utilize preformed folic acid via active transport [3]. * **Resistance:** Bacteria develop resistance by increasing PABA production or altering the enzyme's affinity [3]. * **Adverse Effects:** Watch for **Stevens-Johnson Syndrome (SJS)**, Kernicterus in newborns, and Crystalluria (prevented by alkalinizing urine).

Q: All of the following drugs are contraindicated in patients with G-6-PD deficiency, except?

Ceftriaxone. The core concept behind this question is **Oxidative Stress**. Patients with Glucose-6-Phosphate Dehydrogenase (G-6-PD) deficiency cannot maintain adequate levels of reduced glutathione, which is essential for protecting Red Blood Cells (RBCs) from oxidative damage. When exposed to certain oxidizing drugs, hemoglobin denatures into **Heinz bodies**, leading to acute hemolysis [1]. **Why Ceftriaxone is the correct answer:** Ceftriaxone is a third-generation cephalosporin. Unlike sulfonamides or nitrofurans, cephalosporins do not possess significant oxidizing potential and do not interfere with the pentose phosphate pathway. Therefore, they are safe to use in G-6-PD deficient patients. **Analysis of Incorrect Options:** * **Cotrimoxazole (Sulfamethoxazole + Trimethoprim):** Sulfonamides are classic oxidizing agents and are among the most common triggers for hemolytic anemia in G-6-PD deficiency. * **Furazolidone:** This belongs to the nitrofuran class (like Nitrofurantoin). These drugs undergo redox cycling, generating free radicals that overwhelm the RBC's limited antioxidant capacity. * **Nalidixic acid:** This older quinolone is a known oxidative stressor. While newer fluoroquinolones (like Ciprofloxacin) have a lower risk, Nalidixic acid is strictly contraindicated. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for G-6-PD Triggers:** "**AAA**" – **A**ntimalarials (Primaquine, Chloroquine), **A**ntibiotics (Sulfonamides, Nitrofurantoin, Nalidixic acid), and **A**spirin (high doses) [1]. * **Other notable triggers:** Dapsone (highest risk), Rasburicase, and Fava beans (Favism). * **Peripheral Smear Findings:** Look for **"Bite cells"** (degmacytes) and **Heinz bodies** (visualized with supra-vital stains like Crystal Violet).

Q: Which of the following cephalosporins can cause thrombocytopenia?

Ceftriaxone. **Explanation:** **Ceftriaxone** is a third-generation cephalosporin widely used for its broad-spectrum activity and long half-life. While cephalosporins are generally associated with immune-mediated hemolytic anemia, **Ceftriaxone** is specifically linked to **immune-mediated thrombocytopenia**. This occurs via a drug-induced antibody mechanism where the drug (or its metabolite) binds to platelets, leading to their peripheral destruction. Additionally, Ceftriaxone is unique for causing "biliary sludge" or pseudolithiasis due to its high biliary excretion. **Analysis of Incorrect Options:** * **Cefazolin (Option A):** A first-generation cephalosporin primarily used for surgical prophylaxis. While it can rarely cause leukopenia, it is not the classic answer for drug-induced thrombocytopenia in this context. * **Cefamandole (Option B):** A second-generation cephalosporin known for its **N-methylthiotetrazole (NMTT) side chain**. This side chain causes hypoprothrombinemia (bleeding due to Vitamin K inhibition) and Disulfiram-like reactions, rather than direct thrombocytopenia. * **Ceftobiprole (Option D):** A fifth-generation cephalosporin with activity against MRSA. Its side effect profile focuses more on gastrointestinal upset and dysgeusia (taste disturbance). **High-Yield Clinical Pearls for NEET-PG:** * **NMTT Side Chain Drugs:** Cefamandole, Cefotetan, and Cefoperazone. Remember the mnemonic: *"Man, Tan, Operazone"* for bleeding risks and Disulfiram reactions. * **Ceftriaxone Contraindication:** Avoid in neonates receiving intravenous Calcium (e.g., Calcium Gluconate) due to the risk of fatal **Ceftriaxone-Calcium precipitates** in lungs and kidneys. * **Excretion:** Most cephalosporins are renally excreted; however, **Ceftriaxone and Cefoperazone** are primarily excreted in the bile and do not require dose adjustment in renal failure.

Q: If a drug is active against the pre-erythrocytic stage of the malaria parasite, it will be useful as:

Causal prophylactic. ### Explanation To answer this question, it is essential to correlate the life cycle of the malaria parasite with the clinical terminology of antimalarial therapy. **1. Why "Causal Prophylactic" is correct:** The **pre-erythrocytic stage** (primary hepatic stage) occurs after a mosquito bite but *before* the parasite enters the red blood cells. Drugs that act at this stage prevent the parasite from ever reaching the bloodstream. Therefore, they prevent the initiation of the infection entirely. This is termed **Causal Prophylaxis**. * *Example:* **Primaquine** and **Atovaquone** act as causal prophylactics. **2. Why the other options are incorrect:** * **Suppressive Prophylactic:** These drugs act on the **erythrocytic (RBC) stage**. They do not prevent the liver infection but kill the parasites as they emerge into the blood, thereby "suppressing" clinical symptoms. (e.g., Chloroquine, Mefloquine). * **Clinical Curative:** These drugs are used to treat an established infection by targeting the **erythrocytic stage** to terminate a clinical attack of malaria. (e.g., Artemisinins, Quinine). * **Radical Curative:** This refers to the eradication of **hypnozoites** (latent liver stages) of *P. vivax* and *P. ovale* to prevent a relapse. While this is a liver stage, it is "exo-erythrocytic" rather than "pre-erythrocytic." (e.g., Primaquine, Tafenoquine). ### NEET-PG High-Yield Pearls: * **Primaquine** is the "all-rounder": It acts as a causal prophylactic, a radical curative, and a gametocidal agent. * **Proguanil** is a slow-acting causal prophylactic. * **Pyrimethamine** is a sporontocidal agent (prevents development in the mosquito). * **True Prophylaxis** (Causal) is rarely achieved; most travelers use **Suppressive Prophylaxis** (starting before travel and continuing for 4 weeks after returning).

Q: Which of the following drugs is NOT used in the management of CMV retinitis?

Acyclovir. **Explanation:** The correct answer is **Acyclovir**. **1. Why Acyclovir is the correct answer:** Acyclovir is highly effective against Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV), but it has **minimal activity against Cytomegalovirus (CMV)**. This is because Acyclovir requires initial phosphorylation by a viral-specific enzyme called **Thymidine Kinase** to become active. CMV lacks this specific enzyme (it uses a protein kinase called UL97 instead), making Acyclovir ineffective for treating CMV infections like retinitis. **2. Analysis of incorrect options:** * **Ganciclovir:** This is the **drug of choice** for CMV retinitis. It is phosphorylated by the CMV-specific protein kinase **UL97**, allowing it to inhibit CMV DNA polymerase effectively. * **Foscarnet:** An inorganic pyrophosphate analog that directly inhibits viral DNA polymerase without requiring activation by viral kinases. It is used as a second-line agent or when resistance to Ganciclovir occurs. * **Cidofovir:** A nucleotide analog that is already phosphorylated. It does not require viral enzymes for activation and is used for CMV retinitis, particularly in patients with Ganciclovir resistance. **3. NEET-PG High-Yield Pearls:** * **Valganciclovir:** The oral prodrug of Ganciclovir; it is the preferred agent for induction and maintenance therapy of CMV retinitis due to its high oral bioavailability. * **Major Side Effects:** * **Ganciclovir:** Bone marrow suppression (Neutropenia). * **Foscarnet/Cidofovir:** Nephrotoxicity. * **Cidofovir Administration:** Must be given with **Probenecid** and aggressive hydration to reduce nephrotoxicity. * **Letermovir:** A newer drug that inhibits the CMV DNA terminase complex, used for prophylaxis in transplant recipients.

Q: Redman syndrome is a side effect of which of the following drugs?

Vancomycin. **Explanation:** **Correct Answer: B. Vancomycin** Redman syndrome (now more accurately termed **Vancomycin Infusion Reaction**) is a common infusion-related reaction associated with the rapid intravenous administration of Vancomycin. * **Mechanism:** It is a **pseudo-allergic reaction** (not a true IgE-mediated Type I hypersensitivity). Rapid infusion triggers the direct degranulation of mast cells and basophils, leading to the release of **histamine**. * **Clinical Presentation:** Patients develop pruritus, an erythematous rash (flushing) involving the face, neck, and upper torso, and occasionally hypotension. * **Prevention:** It can be prevented by slowing the infusion rate (administering over at least 60 minutes) or pre-treating with antihistamines. **Why other options are incorrect:** * **A. Rifampicin:** Known for causing harmless **orange-red discoloration** of body fluids (urine, sweat, tears). It can also cause a "Flu-like syndrome" if taken irregularly. * **C. Chloramphenicol:** Classically associated with **Gray Baby Syndrome** (due to deficient glucuronidation in neonates) and bone marrow suppression (aplastic anemia). * **D. Tetracycline:** Notable for causing **Fanconi syndrome** (if expired), tooth discoloration in children, and photosensitivity. **High-Yield Clinical Pearls for NEET-PG:** * **Vancomycin** is the drug of choice for **MRSA** (Methicillin-resistant *Staphylococcus aureus*). * Other side effects of Vancomycin include **Ototoxicity** and **Nephrotoxicity** (especially when combined with Aminoglycosides). * If a patient develops Redman syndrome, the immediate step is to **stop or slow the infusion** and administer diphenhydramine.

Q: Which of the following statements regarding chloroquine is FALSE?

It acts only on the exo-erythrocytic cycle of the parasite.. **Explanation:** **1. Why Option A is the Correct (False) Statement:** Chloroquine is a **highly effective blood schizonticide**. It acts primarily on the **erythrocytic stage** of all malaria species (*P. falciparum, P. vivax, P. ovale, and P. malariae*). It has **no activity** against the exo-erythrocytic (liver) stages or latent tissue stages (hypnozoites). Therefore, it cannot prevent relapses in *P. vivax* or *P. ovale* infections. **2. Analysis of Other Options:** * **Option B (DNA/RNA):** While the primary mechanism of chloroquine is the inhibition of heme polymerase (preventing the conversion of toxic heme to non-toxic hemozoin), it also intercalates into the parasite’s DNA and inhibits RNA synthesis at higher concentrations. * **Option C (Pigmentation):** Long-term use of chloroquine (often for rheumatological conditions) can lead to bluish-grey or slate-grey pigmentation of the nails, hard palate, and skin due to drug-melanin complexes. * **Option D (Drug Accumulation):** Chloroquine is a weak base. It concentrates significantly (up to 100-fold) within the acidic food vacuoles of **infected erythrocytes** compared to uninfected ones, which is central to its selective toxicity. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Resistance:** Mutation in the **PfCRT** (Plasmodium falciparum Chloroquine Resistance Transporter) gene, which pumps the drug out of the vacuole. * **Ocular Toxicity:** Causes "Bull’s Eye Maculopathy" (retinopathy) due to binding with melanin in the retina. * **Drug of Choice:** Still the DOC for sensitive malaria and malaria in **pregnancy**. * **Contraindication:** Avoid in patients with G6PD deficiency (risk of hemolysis) and Psoriasis (may exacerbate skin lesions).

Question 1

Anterior nares is the most common site of colonization in the carrier state of MRSA. What is the best treatment?

Accepted Answer

Topical mupirocin

Answer

Oral Vancomycin

Answer

Inhaled colistin

Answer

IV cefazolin

Question 2

Sulfonamides inhibit bacterial synthesis of folic acid by:

Accepted Answer

Competitive inhibition.

Answer

Uncompetitive inhibition.

Answer

Allosteric inhibition.

Answer

Non-competitive inhibition.

Question 3

All of the following drugs are contraindicated in patients with G-6-PD deficiency, except?

Accepted Answer

Ceftriaxone

Answer

Cotrimoxazole

Answer

Furazolidone

Answer

Nalidixic acid

Question 4

Which of the following cephalosporins can cause thrombocytopenia?

Accepted Answer

Ceftriaxone

Answer

Cefazolin

Answer

Cefamandole

Answer

Ceftabiprole

Question 5

If a drug is active against the pre-erythrocytic stage of the malaria parasite, it will be useful as:

Accepted Answer

Causal prophylactic

Answer

Suppressive prophylactic

Answer

Clinical curative

Answer

Radical curative

Question 6

Which of the following drugs is NOT used in the management of CMV retinitis?

Accepted Answer

Acyclovir

Answer

Foscarnet

Answer

Ganciclovir

Answer

Cidofovir

Question 7

Which of the following drugs used in the treatment of AIDS patients can cause bone marrow depression?

Accepted Answer

Cotrimoxazole

Answer

Didanosine

Answer

Zalcitabine

Answer

Zidovudine

Question 8

Redman syndrome is a side effect of which of the following drugs?

Accepted Answer

Vancomycin

Answer

Rifampicin

Answer

Chloramphenicol

Answer

Tetracycline

Question 9

Which of the following statements about protease inhibitors in HIV is false?

Accepted Answer

Of all the protease inhibitors, saquinavir is the most powerful inhibitor of CYP3A4.

Answer

They are powerful enzyme inhibitors.

Answer

They cause hepatic toxicity.

Answer

All protease inhibitors are substrates for P-glycoprotein coded by the MDR gene.

Question 10

Which of the following statements regarding chloroquine is FALSE?

Accepted Answer

It acts only on the exo-erythrocytic cycle of the parasite.

Answer

It acts on the DNA and RNA of the parasite.

Answer

It causes pigmentation of the nail and mucosa.

Answer

Infected red blood cells have increased drug accumulation.

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?